LIVIVO - Das Suchportal für Lebenswissenschaften

switch to English language
Erweiterte Suche

Ihre letzten Suchen

  1. AU="Casillas-Suárez, Catalina"
  2. AU="Wildberger, R"
  3. AU="Cao, Zhijun"
  4. AU=Ghosh Asish K
  5. AU="Ouyang, Wenjun"
  6. AU="Drake, Amelia F"
  7. AU="Kötél, Dóra"
  8. AU="Palacios, Florencia"
  9. AU="Cousin, Xavier"
  10. AU="Zhou, Yongfeng"
  11. AU="Nischal, Neeraj"
  12. AU="Reger de Moura, Coralie"
  13. AU="Kazan, Özgür"
  14. AU="Goto, Yoshiyuki"
  15. AU="Gulati, Ajay S"
  16. AU="Dotan, Yaniv"
  17. AU="Anderson, Jessica J"
  18. AU="Cong, Weimin"
  19. AU="Dong, Dianshuai"
  20. AU="Sydenstricker, Agnes V"
  21. AU="Glazer, Peter M"
  22. AU="Zhang, Haocheng"
  23. AU="Low, Tze-Yi"
  24. AU="Ratemi, Haithm W"
  25. AU="Lee, Kristy"
  26. AU="Nénon, Q"
  27. AU="Tang, Yi-Han"
  28. AU="Parodi, Jose F"
  29. AU="Kabata, Yudai"
  30. AU="Butler, Javed"
  31. AU=Du L
  32. AU="Artin, Hewa"
  33. AU="Bardakov, V M"
  34. AU="Sakaguchi, Bungo"
  35. AU="Boo, Irene"
  36. AU="Tam, Victor Wai-Hou"
  37. AU="Pierfrancesco Pagella"
  38. AU=Sanchez Garcia Elisabet
  39. AU=Yasir Kashif Ammar
  40. AU="Gümüş, Funda"
  41. AU=Bhowmik Deep AU=Bhowmik Deep
  42. AU="Eugene, Alexis"
  43. AU="Janesomboon, Sujintana"
  44. AU="Sonkhya, Nishi"
  45. AU="Vaz, André"
  46. AU="Rugo, Hope S"
  47. AU="Gupta, Sonia"
  48. AU="Molday, Robert S"
  49. AU="Yaodong Hu"
  50. AU=Gimenez-Mascarell Paula
  51. AU="Orlandi, D"
  52. AU="Takeishi, Yasuchika"
  53. AU="Kamath, Karthik Shantharam" AU="Kamath, Karthik Shantharam"
  54. AU="Innocente, Alessandra"
  55. AU="Xing, Lei"
  56. AU="Chen, Mingyu"
  57. AU="Riedl, Sophie"
  58. AU="Ding, Haiyan"
  59. AU=Hu Xiumei AU=Hu Xiumei
  60. AU="Simmonds, Peter"
  61. AU="Chaturvedi, Apeksha"
  62. AU="Madden, Wyatt"
  63. AU="Wald, Moshe"
  64. AU="Zalesak, J."
  65. AU="Krach, Florian"
  66. AU="Modak, Manisha A"
  67. AU="Ottolini, Matteo"
  68. AU="Douglas Hanahan"
  69. AU="Bieniaszewska, Maria"
  70. AU="Alovisi, Camilla"
  71. AU="Lijfering, Willem M."
  72. AU="Rademacher, Jessica"
  73. AU="Dartigues, Jean-François"
  74. AU="Denicola, Anthony J"
  75. AU="Zhang, Xuewei"
  76. AU="Li, Yanjiao"
  77. AU="Botelho Meireles de Souza, Guilherme"
  78. AU="Gong, Yu-Qing"
  79. AU="Eisch, J"
  80. AU=De Vito Eduardo L
  81. AU="Lowsky, Robert"
  82. AU="Lindner, M."
  83. AU="Mugnai, Giacomo"
  84. AU="Chollet-Krugler, Marylène"
  85. AU="Firsanov, Denis"
  86. AU="Jo, Dong-Gyu"
  87. AU="Greenland, John R"
  88. AU="J Natale"
  89. AU="Drost, Carolin Christina"
  90. AU="Silvera, Risset"
  91. AU="Zgubič, M"
  92. AU="Russo, Rosita"
  93. AU="Ruiz-Ortega, Marta"
  94. AU="T Talbot"
  95. AU="Emoto, Kasey C"
  96. AU="Moos, W H" AU="Moos, W H"
  97. AU=Singh Sweta AU=Singh Sweta
  98. AU="Pimentel, Mauricio"
  99. AU="Kim, Ji Hee"
  100. AU=Ross Jeffrey S
  101. AU=Malhotra Atul
  102. AU="Tiesler, Carla M T"
  103. AU="Merighi, Adalberto" AU="Merighi, Adalberto"

Suchergebnis

Treffer 1 - 7 von insgesamt 7

Suchoptionen

  1. Artikel ; Online: Behavior of COVID-19 in people under 60 years of age in a tertiary hospital in Mexico City.

    Hernández-Solís, Alejandro / Quintanar-Ramírez, M Inés / Quintana-Martínez, Andrea / Casillas-Suárez, Catalina / Álvarez-Maldonado, Pablo / Reding-Bernal, Arturo

    Cirugia y cirujanos

    2022  Band 90, Heft 1, Seite(n) 137–139

    Titelübersetzung Comportamiento de la COVID-19 en personas menores de 60 años en un hospital de tercer nivel de la Ciudad de México.
    Mesh-Begriff(e) COVID-19 ; Humans ; Mexico/epidemiology ; SARS-CoV-2 ; Tertiary Care Centers
    Sprache Englisch
    Erscheinungsdatum 2022-02-05
    Erscheinungsland Mexico
    Dokumenttyp Letter
    ZDB-ID 730699-4
    ISSN 2444-054X ; 0009-7411
    ISSN (online) 2444-054X
    ISSN 0009-7411
    DOI 10.24875/CIRU.21000709
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  2. Artikel ; Online: Changes in lactate dehydrogenase on admission throughout the COVID-19 pandemic and possible impacts on prognostic capability.

    Medina-Hernández, Elba O / Pérez-Navarro, Lucía M / Hernández-Ruiz, Joselín / Villalobos-Osnaya, Alma / L Hernández-Medel, María / Casillas-Suárez, Catalina / Pérez-García, Adolfo

    Biomarkers in medicine

    2022  Band 16, Heft 14, Seite(n) 1019–1028

    Abstract: Introduction: ...

    Abstract Introduction:
    Mesh-Begriff(e) Humans ; COVID-19/enzymology ; COVID-19/epidemiology ; L-Lactate Dehydrogenase/metabolism ; Pandemics ; Prognosis ; Retrospective Studies ; ROC Curve
    Chemische Substanzen L-Lactate Dehydrogenase (EC 1.1.1.27)
    Sprache Englisch
    Erscheinungsdatum 2022-09-02
    Erscheinungsland England
    Dokumenttyp Randomized Controlled Trial ; Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2481014-9
    ISSN 1752-0371 ; 1752-0363
    ISSN (online) 1752-0371
    ISSN 1752-0363
    DOI 10.2217/bmm-2022-0364
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  3. Artikel ; Online: Pulmonary Embolism (PE) Prevalence in Mexican-Mestizo Patients With Severe SARS-COV-2 (COVID-19) Pneumonia At A Tertiary-Level Hospital: A Review.

    Cueto-Robledo, Guillermo / Navarro-Vergara, Dulce-Iliana / Roldan-Valadez, Ernesto / Garcia-Cesar, Marisol / Graniel-Palafox, Luis-Eugenio / Cueto-Romero, Hector-Daniel / Perez-Calatayud, Angel-Augusto / Enriquez-Garcia, Rocio / Casillas-Suarez, Catalina

    Current problems in cardiology

    2022  Band 48, Heft 8, Seite(n) 101208

    Abstract: Since the report of the first case of COVID-19 in Wuhan, China, on December 31, 2019, several associated thrombotic complications have been reported, mainly venous thromboembolic events, and myocardial infarctions, in addition to peripheral arterial ... ...

    Abstract Since the report of the first case of COVID-19 in Wuhan, China, on December 31, 2019, several associated thrombotic complications have been reported, mainly venous thromboembolic events, and myocardial infarctions, in addition to peripheral arterial thrombosis and cerebral vascular events, which have been attributed to a hypercoagulable state. We aimed to know the prevalence and prognostic biomarkers in patients with pulmonary thromboembolism (PE) and SARS Cov-2 pneumonia. Hospitalized patients with SARS Cov-2 pneumonia who have had clinical, biomarker, and imaging data (chest angiography) of pulmonary thromboembolism were included. Descriptive statistics and prevalence rates were calculated. For the analysis between the groups, the paired Student's t and the Wilcoxon test were performed. CT angiography was performed on 26 patients at our institution, with a diagnosis of severe pneumonia secondary to SARS-CoV2. 9 of the patients (34.6%) had a venous thromboembolic disease. Type 2 DM was the most frequent comorbidity up to 55.5% of the total; it was followed by obesity and overweight in 55.5%, and in third place, by systemic arterial hypertension in 33.3% of the cases, 1 (11.1%) patient had chronic kidney disease and 1 (11.1%) patient with a history of cancer, only 1 patient met criteria and was treated with thrombolysis. 6 (66.6%) of the patients had segmental PE, 3 (33.3%) patients had subsegmental PE, and 4 (44.4%) patients presented pulmonary infarction.
    Mesh-Begriff(e) Humans ; COVID-19/complications ; COVID-19/epidemiology ; Hospitals ; Prevalence ; Pulmonary Embolism/epidemiology ; Pulmonary Embolism/etiology ; RNA, Viral ; SARS-CoV-2 ; Venous Thromboembolism/epidemiology ; Venous Thrombosis
    Chemische Substanzen RNA, Viral
    Sprache Englisch
    Erscheinungsdatum 2022-04-20
    Erscheinungsland Netherlands
    Dokumenttyp Journal Article ; Review
    ZDB-ID 441230-8
    ISSN 1535-6280 ; 0146-2806
    ISSN (online) 1535-6280
    ISSN 0146-2806
    DOI 10.1016/j.cpcardiol.2022.101208
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  4. Artikel: Convalescent Plasma to Treat COVID-19: A Two-Center, Randomized, Double-Blind Clinical Trial.

    Ventura-Enríquez, Yanet / Cabello-Gutiérrez, Carlos / Pérez-Calatayud, Ángel Augusto / Cortina-De la Rosa, Evelyn / Fareli-González, Christian Javier / Castillo-Juárez, Paola / Carlos, Alberto Peña-Pérez / Zavaleta-Martínez, Elí Omar / Diaz-Padilla, Elizabeth / Murrieta, Sandra / Álvarez-Jiménez, Violeta Deyanira / Ponce-Medrano, Juan Alberto Díaz / Casillas-Suárez, Catalina / Ocampo-Ocampo, María Angelica / Vargas-De-León, Cruz / Fernández-Sánchez, Verónica

    Life (Basel, Switzerland)

    2022  Band 12, Heft 11

    Abstract: Background: The use of convalescent plasma (CP) has been considered for its immunological mechanisms that could benefit patients in moderate and severe stages of COVID-19. This study evaluated the safety and efficacy of the use of donor CP for COVID-19. ... ...

    Abstract Background: The use of convalescent plasma (CP) has been considered for its immunological mechanisms that could benefit patients in moderate and severe stages of COVID-19. This study evaluated the safety and efficacy of the use of donor CP for COVID-19. Material and methods: A double-blind, randomized controlled clinical trial was conducted from May to October 2020. Thirty-nine participants with moderate (II) and severe (III) stages of COVID-19 confirmed by RT-PCR were included. The study randomization rate was set at 3:1. CPs were chosen for application with a neutralizing antibody titer of ≥1:32. Results: We observed a significantly lower 21-day post-transfusion mortality HR: 0.17 (95.0% CI [0.07−0.45, p < 0.001]) in the group receiving CP compared with the control group; protective units (PU) in the group receiving convalescent plasma after seven days were significantly higher (512 (32−16,384) vs. 96 (32−256), p = 0.01); the PAO2/FIO2 index showed a significant improvement in the group receiving CP (251.01 (109.4) vs. 109.2 (62.4), p < 0.001, in the control group). Conclusion: CP is safe and effective, as it decreased mortality in the CP group compared with the control group.
    Sprache Englisch
    Erscheinungsdatum 2022-11-02
    Erscheinungsland Switzerland
    Dokumenttyp Journal Article
    ZDB-ID 2662250-6
    ISSN 2075-1729
    ISSN 2075-1729
    DOI 10.3390/life12111767
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  5. Artikel ; Online: Differential activation of innate and adaptive lymphocytes during latent or active infection with Mycobacterium tuberculosis.

    Ruiz-Sánchez, Bibiana Patricia / Castañeda-Casimiro, Jessica / Cabrera-Rivera, Graciela L / Brito-Arriola, Owen Marlon / Cruz-Zárate, David / García-Paredes, Víctor Gabriel / Casillas-Suárez, Catalina / Serafín-López, Jeanet / Chacón-Salinas, Rommel / Estrada-Parra, Sergio / Escobar-Gutiérrez, Alejandro / Estrada-García, Iris / Hernández-Solis, Alejandro / Wong-Baeza, Isabel

    Microbiology and immunology

    2022  Band 66, Heft 10, Seite(n) 477–490

    Abstract: Most individuals infected with Mycobacterium tuberculosis (Mtb) have latent tuberculosis (TB), which can be diagnosed with tests (such as the QuantiFERON-TB Gold test [QFT]) that detect the production of IFN-γ by memory T cells in response to the Mtb- ... ...

    Abstract Most individuals infected with Mycobacterium tuberculosis (Mtb) have latent tuberculosis (TB), which can be diagnosed with tests (such as the QuantiFERON-TB Gold test [QFT]) that detect the production of IFN-γ by memory T cells in response to the Mtb-specific antigens 6 kDa early secretory antigenic target EsxA (Rv3875) (ESAT-6), 10 kDa culture filtrate antigen EsxB (Rv3874) (CFP-10), and Mtb antigen of 7.7 kDa (Rv2654c) (TB7.7). However, the immunological mechanisms that determine if an individual will develop latent or active TB remain incompletely understood. Here we compared the response of innate and adaptive peripheral blood lymphocytes from healthy individuals without Mtb infection (QFT negative) and from individuals with latent (QFT positive) or active TB infection, to determine the characteristics of these cells that correlate with each condition. In active TB patients, the levels of IFN-γ that were produced in response to Mtb-specific antigens had high positive correlations with IL-1β, TNF-α, MCP-1, IL-6, IL-12p70, and IL-23, while the proinflammatory cytokines had high positive correlations between themselves and with IL-12p70 and IL-23. These correlations were not observed in QFT-negative or QFT-positive healthy volunteers. Activation with Mtb-soluble extract (a mixture of Mtb antigens and pathogen-associated molecular patterns [PAMPs]) increased the percentage of IFN-γ-/IL-17-producing NK cells and of IL-17-producing innate lymphoid cell 3 (ILC3) in the peripheral blood of active TB patients, but not of QFT-negative or QFT-positive healthy volunteers. Thus, active TB patients have both adaptive and innate lymphocyte subsets that produce characteristic cytokine profiles in response to Mtb-specific antigens or PAMPs. These profiles are not observed in uninfected individuals or in individuals with latent TB, suggesting that they are a response to active TB infection.
    Mesh-Begriff(e) Antigens, Bacterial ; Cytokines ; Humans ; Immunity, Innate ; Interleukin-17 ; Interleukin-23 ; Interleukin-6 ; Latent Tuberculosis ; Lymphocytes ; Mycobacterium tuberculosis ; Pathogen-Associated Molecular Pattern Molecules ; Tuberculosis ; Tumor Necrosis Factor-alpha
    Chemische Substanzen Antigens, Bacterial ; Cytokines ; Interleukin-17 ; Interleukin-23 ; Interleukin-6 ; Pathogen-Associated Molecular Pattern Molecules ; Tumor Necrosis Factor-alpha
    Sprache Englisch
    Erscheinungsdatum 2022-08-17
    Erscheinungsland Australia
    Dokumenttyp Journal Article
    ZDB-ID 224792-6
    ISSN 1348-0421 ; 0385-5600
    ISSN (online) 1348-0421
    ISSN 0385-5600
    DOI 10.1111/1348-0421.13019
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  6. Artikel ; Online: The Age-AST-D Dimer (AAD) Regression Model Predicts Severe COVID-19 Disease.

    Higuera-de-la-Tijera, Fátima / Servín-Caamaño, Alfredo / Reyes-Herrera, Daniel / Flores-López, Argelia / Robiou-Vivero, Enrique J A / Martínez-Rivera, Felipe / Galindo-Hernández, Victor / Rosales-Salyano, Victor H / Casillas-Suárez, Catalina / Chapa-Azuela, Oscar / Chávez-Morales, Alfonso / Jiménez-Bobadilla, Billy / Hernández-Medel, María L / Orozco-Zúñiga, Benjamín / Zacarías-Ezzat, Jed R / Camacho, Santiago / Pérez-Hernández, José L

    Disease markers

    2021  Band 2021, Seite(n) 6658270

    Abstract: Aim: Coronavirus disease (COVID-19) ranges from mild clinical phenotypes to life-threatening conditions like severe acute respiratory syndrome (SARS). It has been suggested that early liver injury in these patients could be a risk factor for poor ... ...

    Abstract Aim: Coronavirus disease (COVID-19) ranges from mild clinical phenotypes to life-threatening conditions like severe acute respiratory syndrome (SARS). It has been suggested that early liver injury in these patients could be a risk factor for poor outcome. We aimed to identify early biochemical predictive factors related to severe disease development with intensive care requirements in patients with COVID-19.
    Methods: Data from COVID-19 patients were collected at admission time to our hospital. Differential biochemical factors were identified between seriously ill patients requiring intensive care unit (ICU) admission (ICU patients) versus stable patients without the need for ICU admission (non-ICU patients). Multiple linear regression was applied, then a predictive model of severity called
    Results: Derivation cohort: from 166 patients included, there were 27 (16.3%) ICU patients that showed higher levels of liver injury markers (
    Conclusions: The elevation of AST (a possible marker of early liver injury) along with DD and age efficiently predict early (at admission time) probability of ICU admission during the clinical course of COVID-19. The AAD model can improve the comprehensive management of COVID-19 patients, and it could be useful as a triage tool to early classify patients with a high risk of developing a severe clinical course of the disease.
    Mesh-Begriff(e) Adult ; Aspartate Aminotransferases/chemistry ; COVID-19/pathology ; COVID-19/therapy ; COVID-19/virology ; Cohort Studies ; Dimerization ; Female ; Humans ; Intensive Care Units ; Male ; Middle Aged ; SARS-CoV-2/isolation & purification ; Severity of Illness Index
    Chemische Substanzen Aspartate Aminotransferases (EC 2.6.1.1)
    Sprache Englisch
    Erscheinungsdatum 2021-03-23
    Erscheinungsland United States
    Dokumenttyp Journal Article
    ZDB-ID 604951-5
    ISSN 1875-8630 ; 0278-0240
    ISSN (online) 1875-8630
    ISSN 0278-0240
    DOI 10.1155/2021/6658270
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  7. Artikel: Consenso nacional de diagnóstico y tratamiento del cáncer de pulmón de células no pequeñas.

    Arrieta, Oscar / Guzmán-de Alba, Enrique / Alba-López, Luis Felipe / Acosta-Espinoza, Alicia / Alatorre-Alexander, Jorge / Alexander-Meza, José Francisco / Allende-Pérez, Silvia Rosa / Alvarado-Aguilar, Salvador / Araujo-Navarrete, Margarita E / Argote-Greene, Luis Marcelo / Aquino-Mendoza, Cinthia Alejandra / Astorga-Ramos, Alma Magdalena / Austudillo-de la Vega, Horacio / Avilés-Salas, Alejandro / Barajas-Figueroa, Luis Javier / Barroso-Quiroga, Nimbe / Blake-Cerda, Mónica / Cabrera-Galeana, Paula Anel / Calderillo-Ruíz, Germán /
    Campos-Parra, Alma Delia / Cano-Valdez, Ana María / Capdeville-García, Daniel / Castillo-Ortega, Graciano / Casillas-Suárez, Catalina / Castillo-González, Patricia / Corona-Cruz, José Francisco / Correa-Acevedo, María Elma / Cortez-Ramírez, Séfora Sonciry / de la Cruz-Vargas, Jhony Alberto / de la Garza-Salazar, Jaime G / de la Mata-Moya, María Dolores / Domínguez-Flores, María Eugenia / Domínguez-Malagón, Hugo Ricardo / Domínguez-Parra, Luis Manuel / Domínguez-Peregrina, Alfredo / Durán-Alcocer, Jaime / Enríquez-Aceves, María Isabel / Elizondo-Ríos, Abelardo / Escobedo-Sánchez, Moisés Dante / de Villafranca, Pablo Espinosa-Mireles / Flores-Cantisani, Alberto / Flores-Gutiérrez, Juan Pablo / Franco-Marina, Francisco / Franco-González, Edwin Efraín / Franco-Topete, Ramón Antonio / Fuentes-de la Peña, Homero / Galicia-Amor, Susana / Gallardo-Rincón, Dolores / Gamboa-Domínguez, Armando / García-Andreu, Jorge / García-Cuéllar, Claudia María / García-Sancho-Figueroa, María Cecilia / García-Torrentera, Rogelio / Gerson-Cwilich, Raquel / Gómez-González, Arturo / Green-Schneeweiss, León / Guillén-Núñez, María del Rocío / Gutiérrez-Velázquez, Hilda / Ibarra-Pérez, Carlos / Jiménez-Fuentes, Edgardo / Juárez-Sánchez, Paula / Juárez-Ramiro, Alejandro / Kelly-García, Javier / Kuri-Exsome, Roberto / Lázaro-León, Jesús Miguel / León-Rodríguez, Eucario / Llanos-Osuna, Sara / Loyola-García, Ulises / López-González, José Sullivan / López y de Antuñano, Francisco Javier / Loustaunau-Andrade, Marco Antonio / Macedo-Pérez, Eleazar Omar / Machado-Villarroel, Limberth / Magallanes-Maciel, Manuel / Martínez-Barrera, Luis / Martínez-Cedillo, Jorge / Martínez-Martínez, Gloria / Medina-Esparza, Alfredo / Meneses-García, Abelardo / Mohar-Betancourt, Alejandro / Morales Blanhir, Jaime / Morales-Gómez, José / Motola-Kuba, Daniel / Nájera-Cruz, Marcela Patricia / Núñez-Valencia, Carolina del Carmen / Ocampo-Ocampo, María Angélica / Ochoa-Vázquez, María Dolores / Olivares-Torres, Carlos A / Palomar-Lever, Andrés / Patiño-Zarco, Mario / Pérez-Padilla, Rogelio / Peña-Alonso, Yolanda Rocío / Pérez-Romo, Alfredo Rafael / Aquilino Pérez, Mario / Pinaya-Ruíz, Paulo Martín / Pointevin-Chacón, María Adela / Poot-Braga, Juan José / Posadas-Valay, Rodolfo / Ramirez-Márquez, Marcelino / Reyes-Martínez, Ivonne / Robledo-Pascual, Julio / Rodríguez-Cid, Jerónimo / Rojas-Marín, Carlos Enrique / Romero-Bielma, Elizabeth / Rubio-Gutiérrez, Jaime Ernesto / Sáenz-Frías, Julia Angelina / Salazar-Lezama, Miguel Angel / Sánchez-Lara, Karla / Sansores Martínez, Raúl / Santillán-Doherty, Patricio / Alejandro-Silva, Juan / Téllez-Becerra, José Luis / Toledo-Buenrostro, Vinicio / Torre-Bouscoulet, Luis / Torecillas-Torres, Laura / Torres, Marineé / Tovar-Guzmán, Víctor / Turcott-Chaparro, Jenny Georgina / Vázquez-Cortés, Jesús Javier / Vázquez-Manríquez, María Eugenia / Vilches-Cisneros, Natalia / Villegas-Elizondo, José Felipe / Zamboni, Mauro M / Zamora-Moreno, Jesús / Zinser-Sierra, Juan W

    Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion

    2013  Band 65 Suppl 1, Seite(n) S5–84

    Abstract: Mexican specialists in oncology, oncologic surgery, thoracic surgery, pneumology, pathology, molecular biology, anesthesiology, algology, psychology, nutrition, and rehabilitation (all of them experts in lung cancer treatment) in order to develop the ... ...

    Titelübersetzung National consensus of diagnosis and treatment of non-small cell lung cancer.
    Abstract Mexican specialists in oncology, oncologic surgery, thoracic surgery, pneumology, pathology, molecular biology, anesthesiology, algology, psychology, nutrition, and rehabilitation (all of them experts in lung cancer treatment) in order to develop the National Consensus on Lung Cancer. The consensus has been developed as an answer to the need of updated Mexican guidelines for the optimal treatment of the disease, as well as to the requirements that such guidelines be established by multidisciplinary panel, depicting the current attention given to cancer lung cases in Mexico. Thus, this paper analyses the epidemiological review, screening, diagnosis, staging, pathology, translational medicine, and the suitable therapies for early, locally advanced, and metastatic disease in the first, second, and third lines of management, as well as rehabilitation and palliative measures.
    Mesh-Begriff(e) Algorithms ; Carcinoma, Non-Small-Cell Lung/complications ; Carcinoma, Non-Small-Cell Lung/diagnosis ; Carcinoma, Non-Small-Cell Lung/etiology ; Carcinoma, Non-Small-Cell Lung/secondary ; Carcinoma, Non-Small-Cell Lung/therapy ; Decision Trees ; Humans ; Lung Neoplasms/complications ; Lung Neoplasms/diagnosis ; Lung Neoplasms/etiology ; Lung Neoplasms/therapy ; Mexico ; Neoplasm Staging ; Smoking/adverse effects
    Sprache Spanisch
    Erscheinungsdatum 2013-03
    Erscheinungsland Mexico
    Dokumenttyp Consensus Development Conference ; English Abstract ; Journal Article ; Practice Guideline
    ZDB-ID 138348-6
    ISSN 0034-8376
    ISSN 0034-8376
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

Zum Seitenanfang